Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...

According to TipRanks, Papadakis is a 4-star analyst with an average return of 3.8% and a 52.68% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as Novo Nordisk, Novartis ...